PMC:7144273 / 52207-52533
Annnotations
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T838 | 111-121 | GO:0065007 | denotes | monitoring |
| T839 | 264-291 | CHEBI:67079;CHEBI:67079 | denotes | anti-inflammatory mediators |
| T840 | 296-313 | CL:0009002 | denotes | inflammatory cell |
| T29856 | 111-121 | GO:0065007 | denotes | monitoring |
| T38267 | 264-291 | CHEBI:67079;CHEBI:67079 | denotes | anti-inflammatory mediators |
| T40683 | 296-313 | CL:0009002 | denotes | inflammatory cell |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T490 | 147-151 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T491 | 309-313 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T733 | 147-151 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T734 | 309-313 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T230 | 0-326 | Sentence | denotes | We also strongly advocate for utilising clinical samples, obtained as part of appropriate clinical care or for monitoring adverse events following cell administration, to obtain mechanistic information including but not limited to analyses of circulating pro- and anti-inflammatory mediators and inflammatory cell populations. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1438 | 40-56 | Species | denotes | clinical samples | Tax:191496 |
| 1441 | 90-98 | Species | denotes | clinical | Tax:191496 |